Smith Thornton Advisors’s VictoryShares US EQ Income Enhanced Volatility Wtd ETF CDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$623K Sell
8,186
-68
-0.8% -$4.95K 0.27% 73
2026
Q1
$590K Sell
8,254
-225
-3% -$15.9K 0.3% 73
2025
Q4
$559K Hold
8,479
0.28% 76
2025
Q3
$566K Sell
8,479
-1
-0% -$66 0.3% 74
2025
Q2
$540K Sell
8,480
-100
-1% -$6.24K 0.31% 72
2025
Q1
$564K Sell
8,580
-31,144
-78% -$2.01M 0.35% 68
2024
Q4
$2.49M Sell
39,724
-1,481
-4% -$96.2K 1.57% 20
2024
Q3
$2.68M Sell
41,205
-626
-1% -$38.8K 1.76% 15
2024
Q2
$2.45M Buy
+41,831
New +$2.46M 1.8% 17

Other funds holding CDC

Smith Thornton Advisors's CDC Position: Q2 2026 in Review

Smith Thornton Advisors reduced its VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) stake by 0.82% in Q2 2026, selling an estimated $4.95K and leaving 8,186 shares worth $623K. The position accounts for 0.27% of the portfolio, ranked #73.

Smith Thornton Advisors first reported a position in CDC in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.68M in Q3 2024. 101 funds tracked by Wall St. Rank hold CDC as of Q2 2026.

  • Smith Thornton Advisors held 8,186 shares of VictoryShares US EQ Income Enhanced Volatility Wtd ETF worth $623K as of Q2 2026.
  • Smith Thornton Advisors sold 68 VictoryShares US EQ Income Enhanced Volatility Wtd ETF shares in Q2 2026, an estimated $4.95K.
  • VictoryShares US EQ Income Enhanced Volatility Wtd ETF made up 0.27% of Smith Thornton Advisors's portfolio in Q2 2026, its #73 holding.
  • Smith Thornton Advisors first reported a position in VictoryShares US EQ Income Enhanced Volatility Wtd ETF in Q2 2024 and has held it in 9 quarters since.
  • Smith Thornton Advisors's VictoryShares US EQ Income Enhanced Volatility Wtd ETF position peaked at $2.68M in Q3 2024.
  • 101 funds tracked by Wall St. Rank held VictoryShares US EQ Income Enhanced Volatility Wtd ETF as of Q2 2026.

Based on Smith Thornton Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.